JPWO2022190626A1 - - Google Patents

Info

Publication number
JPWO2022190626A1
JPWO2022190626A1 JP2023505158A JP2023505158A JPWO2022190626A1 JP WO2022190626 A1 JPWO2022190626 A1 JP WO2022190626A1 JP 2023505158 A JP2023505158 A JP 2023505158A JP 2023505158 A JP2023505158 A JP 2023505158A JP WO2022190626 A1 JPWO2022190626 A1 JP WO2022190626A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023505158A
Other languages
Japanese (ja)
Other versions
JPWO2022190626A5 (https=
JP7626491B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022190626A1 publication Critical patent/JPWO2022190626A1/ja
Publication of JPWO2022190626A5 publication Critical patent/JPWO2022190626A5/ja
Application granted granted Critical
Publication of JP7626491B2 publication Critical patent/JP7626491B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
JP2023505158A 2021-03-12 2022-01-14 Ｓｎ－３８誘導体、当該誘導体を含むナノ粒子、医薬及び当該ナノ粒子の製造方法 Active JP7626491B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021040799 2021-03-12
JP2021040799 2021-03-12
PCT/JP2022/001163 WO2022190626A1 (ja) 2021-03-12 2022-01-14 Ｓｎ－３８誘導体、当該誘導体を含むナノ粒子、医薬及び当該ナノ粒子の製造方法

Publications (3)

Publication Number Publication Date
JPWO2022190626A1 true JPWO2022190626A1 (https=) 2022-09-15
JPWO2022190626A5 JPWO2022190626A5 (https=) 2024-05-01
JP7626491B2 JP7626491B2 (ja) 2025-02-04

Family

ID=83226544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023505158A Active JP7626491B2 (ja) 2021-03-12 2022-01-14 Ｓｎ－３８誘導体、当該誘導体を含むナノ粒子、医薬及び当該ナノ粒子の製造方法

Country Status (6)

Country Link
US (1) US20240300979A1 (https=)
EP (1) EP4306527A4 (https=)
JP (1) JP7626491B2 (https=)
CN (1) CN117015545A (https=)
AU (1) AU2022234045B2 (https=)
WO (1) WO2022190626A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115844891B (zh) * 2022-11-04 2025-02-11 沈阳药科大学 二硫键桥连的sn38二聚体前药及其自组装纳米粒、制备方法与应用
AU2023390747A1 (en) 2022-12-09 2025-06-26 Japan Science And Technology Agency Compound, nanoparticles, medicine and method for producing nanoparticles

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011155501A1 (ja) * 2010-06-11 2011-12-15 独立行政法人科学技術振興機構 薬剤多量体微粒子及びその製造方法
JP2016534092A (ja) * 2013-07-23 2016-11-04 イミューノメディクス、インコーポレイテッドＩｍｍｕｎｏｍｅｄｉｃｓ， Ｉｎｃ． Ｃｌ２ａリンカーを有する抗体−ｓｎ−３８免疫複合体
CN107669626A (zh) * 2017-09-03 2018-02-09 河南师范大学 一种高载药量的还原敏感的药物传递系统的制备方法及其应用
JP2018520148A (ja) * 2012-12-13 2018-07-26 イミューノメディクス、インコーポレイテッドＩｍｍｕｎｏｍｅｄｉｃｓ， Ｉｎｃ． Ｃｌ２ａリンカーを有する抗体−ｓｎ−３８免疫抱合体
WO2019236954A1 (en) * 2018-06-07 2019-12-12 Seattle Genetics, Inc. Camptothecin conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021040799A (ja) 2019-09-09 2021-03-18 西川　基守 パチンコ遊技機

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011155501A1 (ja) * 2010-06-11 2011-12-15 独立行政法人科学技術振興機構 薬剤多量体微粒子及びその製造方法
JP2018520148A (ja) * 2012-12-13 2018-07-26 イミューノメディクス、インコーポレイテッドＩｍｍｕｎｏｍｅｄｉｃｓ， Ｉｎｃ． Ｃｌ２ａリンカーを有する抗体−ｓｎ−３８免疫抱合体
JP2016534092A (ja) * 2013-07-23 2016-11-04 イミューノメディクス、インコーポレイテッドＩｍｍｕｎｏｍｅｄｉｃｓ， Ｉｎｃ． Ｃｌ２ａリンカーを有する抗体−ｓｎ−３８免疫複合体
CN107669626A (zh) * 2017-09-03 2018-02-09 河南师范大学 一种高载药量的还原敏感的药物传递系统的制备方法及其应用
WO2019236954A1 (en) * 2018-06-07 2019-12-12 Seattle Genetics, Inc. Camptothecin conjugates

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GUO, X. ET AL.: "Dimeric Drug Polymeric Micelles with Acid-Active Tumor Targeting and FRET-Traceable Drug Release", ADVANCED MATERIALS, vol. 30, no. 3, JPN6022009149, 2018, pages 1705436 - 1, ISSN: 0005334187 *
HE, D. ET AL.: "Self-assembling nanowires of an amphiphilic camptothecin prodrug derived from homologous derivative", CHEMICAL COMMUNICATIONS, vol. 52, no. 98, JPN7022001040, 2016, pages 14145 - 14148, ISSN: 0005334185 *
WANG, H. ET AL.: "Reduction-Responsive Dithiomaleimide-Based Nanomedicine with High Drug Loading and FRET-Indicated Dr", CHEMICAL COMMUNICATIONS, vol. 51, no. 23, JPN7022001039, 2015, pages 4807 - 4810, ISSN: 0005334186 *

Also Published As

Publication number Publication date
WO2022190626A1 (ja) 2022-09-15
EP4306527A4 (en) 2025-02-19
US20240300979A1 (en) 2024-09-12
AU2022234045A1 (en) 2023-08-31
JP7626491B2 (ja) 2025-02-04
EP4306527A1 (en) 2024-01-17
AU2022234045B2 (en) 2025-05-29
CN117015545A (zh) 2023-11-07

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230421

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240417

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240528

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240711

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240910

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241031

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250114

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250116

R150 Certificate of patent or registration of utility model

Ref document number: 7626491

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150